UK markets close in 7 hours 22 minutes

CV Sciences, Inc. (0HRT.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
0.0850-0.0150 (-15.00%)
As of 07:01PM BST. Market open.

CV Sciences, Inc.

9530 Padgett Street
Suite 107
San Diego, CA 92126
United States
866 290 2157
https://www.cvsciences.com

Sector(s)
Industry
Full-time employees42

Key executives

NameTitlePayExercisedYear born
Mr. Joseph D. DowlingCEO, Secretary & Director313.07kN/A1957
Mr. Joerg GrasserChief Financial Officer228kN/A1975
Mr. Tim HitchmanVice President of OperationsN/AN/AN/A
Mr. Jesse KaragianesSenior Vice President of Revenue GrowthN/AN/AN/A
Ms. Alyssa DunnOperations ManagerN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. The company offers its products under the PlusCBD, ProCBD, HappyLane, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. It is also developing cannabinoids intended to treat medical indications, including CVSI-007 that combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.

Corporate governance

CV Sciences, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.